Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 219
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital...
https://www.globenewswire.com/news-release/2021/12/21/2355961/0/en/PharmaTher-Provides-Update-on-Product-Pipeline-and-Expected-Milestones-for-2022.html
Lobe Sciences Announces Publication of PCT Patent Application for Its Combination...
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel
MindMed Provides Status Update on IND for Phase 2b Trial of...
PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara...
HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences...
Two esteemed doctors join CB Therapeutics in its exploration of innovative...
Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles...
Load more